Klausner Richard 4
4 · Lyell Immunopharma, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Klausner Richard
Director
Transactions
- Award
Option (right to buy)
2023-06-16+65,000→ 65,000 totalExercise: $3.19Exp: 2033-06-15→ Common Stock (65,000 underlying)
Holdings
- 988,900(indirect: Grantor)
Common Stock
- 2,967,834
Common Stock
Footnotes (2)
- [F1]Consists of 250,000 shares held by The Ariella Klausner Delaware Trust, 238,900 shares held by The Eli Klausner Delaware Trust, 250,000 shares held by The Isaac Klausner Delaware Trust, and 250,000 shares held by The Olivia Klausner Delaware Trust. The Reporting Person is a grantor of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein. Raymond James Trust Services of Delaware is the trustee of each of the trusts.
- [F2]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 16, 2023 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 16, 2023, subject to the Reporting Person providing continuous service through such date.